Cvs Health Corp Stock Price, News & Analysis

Evolv Technology (NASDAQ: EVLV) has appointed Mario Ramos as Chief Financial Officer, effective November 1, 2021. Ramos, who previously served as CFO at Edelman Financial Engines and held key roles at CVS Health, will oversee the company's finance, accounting, risk compliance, IT, and investor relations. His extensive experience in high-growth environments is expected to support Evolv’s strategic growth initiatives. Ramos succeeds Peter Faubert, who transitions to Senior VP of Strategic Finance. This appointment aligns with Evolv’s mission to enhance security technology in a rapidly growing market.

Aetna, a CVS Health company, launched its Gene-based, Cellular, and Other Innovative Therapies (GCIT) network to improve access to new therapies for rare genetic diseases. Starting January 1, 2022, the network will offer gene therapy services, including Luxturna, Spinraza, and Zolgensma, as part of Aetna's medical benefits. With over 75 designated GCIT service providers, the network aims to manage therapy costs and enhance patient outcomes. A dedicated clinical team will assist members through the healthcare process and provide financial protection for clients lacking traditional stop-loss insurance.

Aetna®, a CVS Health company, announced that 76% of its 2022 Medicare Advantage Prescription Drug (MAPD) members are enrolled in plans rated 4.5 stars or higher, significantly outperforming the industry average of 54%. Furthermore, 87% of members are in plans rated 4 stars or above, with two plans achieving the highest 5-star rating. The announcement reflects Aetna's commitment to quality care amid challenges posed by the COVID-19 pandemic, highlighting their focus on member accessibility and health management. Enrollment for Aetna's Medicare Advantage plans started on October 15, 2021.

CVS Health (NYSE: CVS) has announced the availability of the Moderna COVID-19 booster shot at select CVS Pharmacy locations starting October 22, 2021. This follows CDC authorization and guidance from the Advisory Committee on Immunization Practices (ACIP). Eligible populations include individuals aged 65 and older, those aged 50-64 with underlying health conditions, and others aged 18-49 at high risk. CVS has administered over 34 million COVID-19 vaccines to date and is prepared to expand vaccine eligibility to ages 5-11 upon CDC approval.

The Aetna Connected Plan with CVS Health is an innovative health care offering in the New York/New Jersey market, providing members with a more affordable way to access care. This plan combines the Aetna Open Access network with expanded services at CVS Pharmacy, featuring over 800 locations and 53 CVS HealthHUBs.

Mid-sized businesses can start quoting for the plan now, effective from December 2021. Key benefits include $0 copays at in-network clinics, 90-day prescription refills, and valuable support through Care Concierge services.

CVS Health has announced a quarterly dividend of $0.50 per share, approved by its board of directors. The dividend will be payable on November 1, 2021, to shareholders of record by October 22, 2021. This reflects the company's commitment to returning value to its shareholders.

CVS Health Corporation (NYSE: CVS) will host a conference call on November 3, 2021, at 8:00 a.m. (ET) to discuss its third-quarter 2021 financial results. An audio webcast will be available through the CVS Health Investor Relations website, providing access to interested parties. The webcast will be archived for a year. CVS Health is recognized for delivering comprehensive health solutions, with over 300,000 employees, including more than 40,000 physicians and healthcare professionals, enhancing community health access and affordability.

Aetna, a CVS Health company, announced its 2022 Medicare offerings, emphasizing expanded benefits aimed at improving member health and affordability. With nearly 9.8 million Medicare members, Aetna introduced more than 2.9 million beneficiaries to new Medicare Advantage plans, including $0 premium options available to 84% of eligible beneficiaries. The plans now cover 46 states and D.C., with access extended to additional counties, impacting 53.2 million individuals. Aetna also expanded benefits for Dual Eligible Special Needs Plans and designed specialized coverage for Veterans, addressing social determinants of health.

CVS Health (NYSE: CVS) announced the availability of the Pfizer-BioNTech COVID-19 booster shot starting September 24, 2021, following CDC approval. Eligible populations include individuals 65 and older, those 50-64 with specific medical conditions, and those 18-49 at high risk for severe COVID-19. CVS has administered over 34 million COVID-19 vaccines to date and continues to expand its vaccination efforts, preparing to offer additional booster shots as authorized. CVS encourages appointments for efficiency and accessibility.